{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:34:18Z","timestamp":1764333258206,"version":"3.40.5"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Pathophysiology of pre-eclampsia depends on a defective trophoblastic invasion of uteroplacental blood vessels that leads to placental ischemia and induction of an inflammatory process within the placenta. This process may trigger the expression of Cancer antigen 125 (CA 125), C-reactive protein (CRP) and uric acid (UA). This research aimed to evaluate the association of serum CA 125, CRP and uric acid with Preeclampsia. The study recruited 200 singleton Sudanese pregnant women, who were divided into three groups: controls (n = 100), mild preeclampsia (n = 46) and severe preeclampsia (n = 54). The study subjects were matched for maternal age, gestational age and body mass index. Blood samples were taken for measurement of the different variables using immune- assay and enzymatic automated chemical analysis. The levels of CA 125 in mild and severe preeclampsia were (21.94\u00b10.749 IU\/ml) and (40.78\u00b11.336 IU\/ml) respectively, which was significantly different (<jats:italic>P<\/jats:italic>&lt;0.001) from the control mean (16.48\u00b10.584 IU\/ml). There was also a significant difference between the mean levels of CRP in mild and severe preeclampsia (15.17\u00b10.788 mg\/L), (31.50\u00b11.709 mg\/L) compared with controls (4.79\u00b10.178 mg\/L), (<jats:italic>P<\/jats:italic>&lt;0.01). There was also a significant difference in the mean levels of UA in mild and severe cases (6.44\u00b10.293 and7.37\u00b10.272) in comparison with the controls (4.00\u00b10.061); (<jats:italic>P&lt;0<\/jats:italic>.001). There were significant differences between severe and mild groups (<jats:italic>P&lt;0<\/jats:italic>.05). Cancer antigen 125, CRP and UA levels\u200e correlated positively with mean arterial blood pressure (MAP) where (r &gt;0.7; <jats:italic>P<\/jats:italic> &lt; 0.001). ROC curve validates the utility of these biomarkers for monitoring preeclampsia (AUC &gt;0.8; <jats:italic>P<\/jats:italic> &lt; 0.001). In conclusion CA 125, CRP and UA were significantly higher in preeclampsia compared with the controls. The rise of the analytes was directly associated with the severity of the disease.<\/jats:p>","DOI":"10.1371\/journal.pone.0280256","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T18:30:59Z","timestamp":1674498659000},"page":"e0280256","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cancer antigen 125 and C-reactive protein inflammatory mediators and uric acid in association with preeclampsia in North Kordofan State, Western Sudan"],"prefix":"10.1371","volume":"18","author":[{"given":"Naglaa Abdelbasit","family":"Suliman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khidir Elamin","family":"Awadalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid Hussein","family":"Bakheit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0840-1637","authenticated-orcid":true,"given":"Abdelrahim Osman","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2023,1,23]]},"reference":[{"key":"pone.0280256.ref001","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.preghy.2018.05.004","article-title":"International Society for the Study of Hypertension in Pregnancy (ISSHP). The hypertensive disorders of pregnancy: ISSHP classification, diagnosis and management recommendations for international practice","volume":"13","author":"MA Brown","year":"2018","journal-title":"Pregnancy Hypertension"},{"issue":"4","key":"pone.0280256.ref002","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1471-0528.2004.00071.x","article-title":"Is pre-eclampsia more than one disease?","volume":"111","author":"LJ Vatten","year":"2004","journal-title":"BJOG An Int J Obstet Gynaecol"},{"issue":"2","key":"pone.0280256.ref003","doi-asserted-by":"crossref","DOI":"10.1038\/ki.2014.17","article-title":"Advances in the pathophysiology of pre-eclampsia and related podocyte injury","volume":"86","author":"IM Craici","year":"2014","journal-title":"Kidney Int"},{"issue":"6","key":"pone.0280256.ref004","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.2215\/CJN.12081115","article-title":"Preeclampsia: Updates in pathogenesis, definitions, and guidelines","volume":"11","author":"E Phipps","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9461","key":"pone.0280256.ref005","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(05)17987-2","article-title":"Pre-eclampsia","volume":"365","author":"B Sibai","year":"2005","journal-title":"Lancet"},{"issue":"4","key":"pone.0280256.ref006","article-title":"Preeclampsia: Pathogenesis, Prevention, and Long-Term Complications","volume":"37","author":"B Jim","year":"2017","journal-title":"Semin Nephrol"},{"issue":"1","key":"pone.0280256.ref007","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0002-9378(96)70245-4","article-title":"Biochemical evidence of impaired trophoblastic invasion of decidual stroma in women destined to have preeclampsia","volume":"175","author":"CJM De Groot","year":"1996","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"pone.0280256.ref008","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.2215\/CJN.12081115","article-title":"Mini-Review Preeclampsia: Updates in Pathogenesis, Definitions, and Guidelines","volume":"11","author":"E Phipps","year":"2016","journal-title":"Clin J Am Soc Nephrol 11"},{"key":"pone.0280256.ref009","first-page":"69","article-title":"Endothelial dysfunction in pre-eclampsia","volume":"58","author":"L. Poston","year":"2006","journal-title":"Pharmacol Reports"},{"issue":"3","key":"pone.0280256.ref010","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/apha.12106","article-title":"Pathophysiology of hypertension in pre-eclampsia: A lesson in integrative physiology","volume":"208","author":"AC Palei","year":"2013","journal-title":"Acta Physiol"},{"issue":"SUPPL.","key":"pone.0280256.ref011","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.placenta.2008.11.009","article-title":"The Two Stage Model of Preeclampsia: Variations on the Theme","volume":"30","author":"JM Roberts","year":"2009","journal-title":"Placenta"},{"issue":"3","key":"pone.0280256.ref012","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2215\/CJN.03761106","article-title":"Pathophysiology of the clinical manifestations of preeclampsia","volume":"2","author":"M Hladunewich","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"pone.0280256.ref013","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jmig.2014.10.013","article-title":"Increased Serum Cancer Antigen-125 Is a Marker for Severity of Deep Endometriosis","volume":"22","author":"P Santulli","year":"2015","journal-title":"J Minim Invasive Gynecol"},{"issue":"2","key":"pone.0280256.ref014","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/humupd\/1.2.173","article-title":"Ca125 and endometriosis","volume":"1","author":"M Muyldermans","year":"1995","journal-title":"Hum Reprod Update"},{"key":"pone.0280256.ref015","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1006\/gyno.1996.0253","article-title":"Human Peritoneal Mesothelial Cells Are More Potent Than Ovarian Cancer Cells in Producing Tumor Marker CA-125","volume":"62","author":"Alain G. Zeimet","year":"1996","journal-title":"Gynecologic Oncology"},{"issue":"4","key":"pone.0280256.ref016","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000292701","article-title":"Tumor markers in hypertensive disorders of pregnancy","volume":"35","author":"H Schrocksnadel","year":"1993","journal-title":"Gynecol Obstet Invest"},{"issue":"1","key":"pone.0280256.ref017","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.biopha.2003.11.003","article-title":"Serum tumor markers in the management of ovarian, endometrial and cervical cancer","volume":"58","author":"A Gadducci","year":"2004","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"pone.0280256.ref018","first-page":"416","article-title":"Determination of cancer antigen-125 level and its association with preeclampsia among Sudanese women","volume":"11","author":"A Karrar","year":"2020","journal-title":"Ann Clin Anal Med"},{"issue":"1","key":"pone.0280256.ref019","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1600-0897.2012.01113.x","article-title":"The Mucin MUC16 (CA125) Binds to NK Cells and Monocytes from Peripheral Blood of Women with Healthy Pregnancy and Preeclampsia","volume":"68","author":"C Tyler","year":"2012","journal-title":"Am J Reprod Immunol"},{"issue":"3","key":"pone.0280256.ref020","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000053903","article-title":"Maternal serum CA125 and CA15-3 antigen levels in normal and pathological pregnancy","volume":"16","author":"GG Bon","year":"2001","journal-title":"Fetal Diagn Ther"},{"issue":"2","key":"pone.0280256.ref021","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/10641955.2018.1460667","article-title":"Association between serum CA125 levels in preeclampsia and its severity among women in Lagos, South-West Nigeria","volume":"37","author":"GE Osanyin","year":"2018","journal-title":"Hypertens Pregnancy"},{"issue":"April","key":"pone.0280256.ref022","first-page":"1","article-title":"Role of C-Reactive Protein at Sites of inflammation and infection","volume":"9","author":"NR Sproston","year":"2018","journal-title":"Frontiers in Immunology"},{"issue":"10","key":"pone.0280256.ref023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ijcp.13380","article-title":"Serum CA-125 levels in preeclampsia: A systematic review and meta-analysis","volume":"73","author":"I Bellos","year":"2019","journal-title":"Int J Clin Pract"},{"issue":"1","key":"pone.0280256.ref024","first-page":"1322","article-title":"The Association of Serum Cancer Antigen 125 and C\u2014reactive protein Level with The Severity of Preeclampsia","volume":"5","author":"M Ali","year":"2012","journal-title":"Karbala J. Med"},{"issue":"3","key":"pone.0280256.ref025","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.0000053730.47739.3C","article-title":"Clinical application of C-reactive protein for cardiovascular disease detection and prevention","volume":"107","author":"PM Ridker","year":"2003","journal-title":"Circulation"},{"issue":"3","key":"pone.0280256.ref026","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1471-0528.2002.01130.x","article-title":"Levels of C-reactive protein in pregnant women who subsequently develop pre-eclampsia","volume":"109","author":"MD Savvidou","year":"2002","journal-title":"BJOG An Int J Obstet Gynaecol"},{"issue":"2","key":"pone.0280256.ref027","doi-asserted-by":"crossref","first-page":"183","DOI":"10.31083\/j.ceog.2020.02.5229","article-title":"Prediction of severity of preeclampsia in Egyptian patients: Role of neutrophil\/lymphocyte ratio, platelet\/lymphocyte ratio and C-reactive protein","volume":"47","author":"AE Kholeif","year":"2020","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"2","key":"pone.0280256.ref028","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/10641950802601187","article-title":"CA-125 and CRP are elevated in preeclampsia","volume":"28","author":"FB Cebesoy","year":"2009","journal-title":"Hypertens Pregnancy"},{"issue":"2","key":"pone.0280256.ref029","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.amjhyper.2003.09.011","article-title":"A prospective study of maternal serum C-reactive protein concentrations and risk of preeclampsia","volume":"17","author":"C Qiu","year":"2004","journal-title":"Am J Hypertens"},{"issue":"2","key":"pone.0280256.ref030","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejogrb.2004.12.009","article-title":"Association of fibrinogen and C-reactive protein with severity of preeclampsia","volume":"121","author":"Y \u00dcst\u00fcn","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"pone.0280256.ref031","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1479-828X.1990.tb03246.x","article-title":"Uric Acid in Pregnancy and Preeclampsia: An Alternative Hypothesis","volume":"30","author":"RA Fay","year":"1990","journal-title":"Aust New Zeal J Obstet Gynaecol"},{"issue":"6","key":"pone.0280256.ref032","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/01.HYP.0000188703.27002.14","article-title":"Uric acid is as important as proteinuria in identifying fetal risk in women with gestational hypertension","volume":"46","author":"JM Roberts","year":"2005","journal-title":"Hypertension"},{"issue":"7","key":"pone.0280256.ref033","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.2741\/2244","article-title":"Renal function during normal pregnancy and preeclampsia","volume":"12","author":"A Jeyabalan","year":"2007","journal-title":"Front Biosci"},{"key":"pone.0280256.ref034","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.placenta.2007.11.001","article-title":"Uric Acid as a Pathogenic Factor in Preeclampsia","volume":"29","author":"SA Bainbridge","year":"2008","journal-title":"Placenta"},{"key":"pone.0280256.ref035","first-page":"8","article-title":"Association between Serum Uric Acid Levels and Perinatal Outcome in Women with Preeclampsia","volume":"2021","author":"RU Ugwuanyi","journal-title":"Hindawi Obstetrics and Gynecology International"},{"issue":"6","key":"pone.0280256.ref036","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/01.HYP.0000069700.62727.C5","article-title":"Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease","volume":"41","author":"RJ Johnson","year":"2003","journal-title":"Hypertension"},{"issue":"5","key":"pone.0280256.ref037","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1111\/j.1523-1755.2005.00273.x","article-title":"Hyperuricemia induces endothelial dysfunction","volume":"67","author":"UM Khosla","year":"2005","journal-title":"Kidney Int"},{"key":"pone.0280256.ref038","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.atherosclerosis.2018.10.007","article-title":"Hyperuricemia and endothelial function: From molecular background to clinical perspectives","volume":"278","author":"T Maruhashi","year":"2018","journal-title":"Atherosclerosis"},{"issue":"3","key":"pone.0280256.ref039","doi-asserted-by":"crossref","first-page":"114","DOI":"10.12816\/0033257","article-title":"Serum uric acid in women with preeclampsia compared to normotensive women","volume":"52","author":"AK Al Huri","year":"2016","journal-title":"Sudan Med J"},{"issue":"1","key":"pone.0280256.ref040","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.preghy.2012.11.001","article-title":"The definition of severe and early-onset preeclampsia. Statements from the International Society for the Study of Hypertension in Pregnancy (ISSHP).","volume":"3","author":"AL Tranquilli","year":"2013","journal-title":"Pregnancy Hypertens"},{"issue":"3","key":"pone.0280256.ref041","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00404-010-1736-2","article-title":"Serum concentrations of CA-125 in normal and preeclamptic pregnancies","volume":"284","author":"M Ozat","year":"2011","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"pone.0280256.ref042","first-page":"2279","article-title":"Serum Uric Acid and C-Reactive Protein in Preeclampsia","volume":"14","author":"D Kanti Mandal","year":"2015","journal-title":"IOSR J Dent Med Sci Obs Gynae"},{"key":"pone.0280256.ref043","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0021-9258(18)86658-3","article-title":"The uric acid content of maternal and fetal blood","volume":"32","author":"JM Siemons","year":"1917","journal-title":"J Biol Chem"},{"key":"pone.0280256.ref044","doi-asserted-by":"crossref","first-page":"160: e1","DOI":"10.1016\/j.ajog.2005.06.066","article-title":"Uric acid concentrations in early pregnancy among preeclamptic women with gestational hyperuricemia at delivery","volume":"194","author":"RW Powers","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"pone.0280256.ref045","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/S0140-6736(76)93024-5","article-title":"Plasma-urate measurements in predicting fetal death in hypertensive pregnancy","volume":"1","author":"CW Redman","year":"1976","journal-title":"Lancet"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0280256","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T18:31:41Z","timestamp":1674498701000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0280256"}},"subtitle":[],"editor":[{"given":"Manish S.","family":"Patankar","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,1,23]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0280256","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2023,1,23]]}}}